A Cancer and Leukemia group B phase II study of sunitinib malate in patients with previously treated metastatic pancreatic adenocarcinoma (CALGB 80603)

Eileen M. O'reilly, Donna Niedzwiecki, Margaret Hall, Donna Hollis, Tanios Bekaii-Saab, Timothy Pluard, Kathe Douglas, Ghassan K. Abou-Alfa, Hedy L. Kindler, Richard L. Schilsky, Richard M. Goldberg

Research output: Contribution to journalArticlepeer-review

57 Scopus citations

Fingerprint

Dive into the research topics of 'A Cancer and Leukemia group B phase II study of sunitinib malate in patients with previously treated metastatic pancreatic adenocarcinoma (CALGB 80603)'. Together they form a unique fingerprint.

Medicine & Life Sciences